Literature DB >> 7693710

Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines.

M Koide1, Y Kawahara, I Nakayama, T Tsuda, M Yokoyama.   

Abstract

In cultured vascular smooth muscle cells, interferon gamma (IFN-gamma) induced the accumulation of nitrite, a stable metabolite of nitric oxide, in a dose- and time-dependent manner. In parallel with this reaction, this cytokine increased the mRNA and protein levels of an inducible macrophage-type of nitric oxide synthase (iNOS). Forskolin, a direct activator of adenylate cyclase, or dibutyryl cAMP alone caused small increases in nitrite accumulation and iNOS mRNA and protein levels and synergistically enhanced the IFN-gamma-stimulated reactions. 8-Bromo-cGMP neither increased by itself nor synergized with IFN-gamma to increase the same reactions. Prostaglandin E1 and beraprost, a stable analogue of prostaglandin I2, which by themselves showed only marginal effects on these reactions, also synergized with IFN-gamma to stimulate the reactions. Interleukin 1 beta or tumor necrosis factor alpha stimulated the same reactions which were similarly enhanced by forskolin. These results indicate that an elevation of intracellular cAMP, particularly in combination with inflammatory cytokines, positively regulates nitric oxide production at the level of iNOS mRNA expression in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693710

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.

Authors:  M Cavicchi; B J Whittle
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.

Authors:  M Boese; R Busse; A Mülsch; V Schini-Kerth
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia.

Authors:  C Szabó; G Haskó; B Zingarelli; Z H Németh; A L Salzman; V Kvetan; S M Pastores; E S Vizi
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4D.

Authors:  Venugopal Rajanbabu; Chieh-Yu Pan; Shang-Chun Lee; Wei-Ju Lin; Ching-Chun Lin; Chung-Leung Li; Jyh-Yih Chen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

5.  Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-pig gastric fundus.

Authors:  J M Dick; L A Van Geldre; J P Timmermans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.

Authors:  L Belhassen; R A Kelly; T W Smith; J L Balligand
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

7.  Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells.

Authors:  D Kunz; G Walker; W Eberhardt; U K Messmer; A Huwiler; J Pfeilschifter
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

8.  Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes.

Authors:  P A Bécherel; M D Mossalayi; F Ouaaz; L Le Goff; B Dugas; N Paul-Eugène; C Frances; O Chosidow; E Kilchherr; J J Guillosson
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells.

Authors:  R M Nüsing; T Klein; J Pfeilschifter; V Ullrich
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 10.  Nitric oxide synthase: expression and expressional control of the three isoforms.

Authors:  U Förstermann; H Kleinert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.